General Information


DRACP ID  DRACP04039

Peptide Name  

Sequence  ICRKPIICRKPIICRKPIICRKPIICRKPI

Sequence Length  30

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C160H292N50O31S5

Absent amino acids  ADEFGHLMNQSTVWY

Common amino acids  I

Mass  409016

Pl  11.27

Basic residues  10

Acidic residues  0

Hydrophobic residues  10

Net charge  10

Boman Index  -4675

Hydrophobicity  25

Aliphatic Index  130

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  250

Absorbance 280nm  8.62

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32706256

Title  Rational Avoidance of Protease Cleavage Sites and Symmetrical End-Tagging Significantly Enhances the Stability and Therapeutic Potential of Antimicrobial Peptides

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16419

DRACP is developed by Dr.Zheng's team.